Ruzasvir has demonstrated highly potent and pan-genotypic antiviral activity in preclinical (picomolar range) and clinical studies. Ruzasvir has been administered to over 2,100 subjects at daily doses ...

Incyte (Nasdaq:INCY) today announced that data from key programs in its oncology portfolio will be presented in both oral and poster sessions at the 2025 American Society of Hematology (ASH) Annual ...

Discover a practical blueprint for building a modern, intelligence-driven threat program aligned with enterprise risk and ...

From tumor profiling to CAR-T optimization, AI is accelerating discovery and decision-making in immuno-oncology. PICI researchers are leveraging multimodal data and large language models to predict ...

A2 Biotherapeutics, Inc. (A2 Bio), a clinical-stage cell therapy company developing first-in-class logic-gated cell therapies for solid tumors, today announced the presentation of safety and early ...

PROENERGY today announced a $1 million gift to the United Way of San Antonio and Bexar County's Safety Net Program. The gift ...

Innovaccer Inc., a leading healthcare AI company, today announced that it has been selected by the PopHealth Learning Center (Learning Center or PHLC) to deliver a statewide population health ...

As teachers in the Imperial Valley plan lessons for the rest of the school year, many may be looking for ways to make ...

Decoupling local tax policies from the federal tax cuts passed by Congress means the city will avoid a revenue hit of nearly ...

Your daughter aced her freshman biology class and came home announcing she wants to be a biomedical engineer. Meanwhile, your ...

Background Relationships and sex education (RSE) impacts some sexual behaviours but could be strengthened by incorporating ...

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) ('SELLAS’’ or the 'Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer ...